Skip to Main Content

Paper Details

Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer.
Ther Adv Med Oncol
0
2023
Author NameAffiliation
Steven J IsakoffMassachusetts General Hospital
Steven J IsakoffHarvard Medical School
Aditya BardiaMassachusetts General Hospital
Aditya BardiaHarvard Medical School
  • 1 - 4

Datasets

Release 1.2